Publication ethics and malpractice statement
MP Journal of Medical Research follows the Principles of Transparency and Best Practice in Scholarly Publishing and the guidelines of the Committee on Publication Ethics (COPE). This statement sets out the responsibilities of editors, reviewers and authors, and what happens when they are not met.
Peer review
Every submission is first checked by the editorial office for completeness and consistency with the poster presented: title, authors and affiliations, structured abstract, key figure and congress.
It is then reviewed by at least one member of the Editorial Board whose specialty matches the work, who assesses its scientific consistency and ethical compliance and recommends acceptance, revision or rejection. The final decision is taken by the Editorial Board.
Review is single-anonymized: reviewers know the identity of the authors; authors are not told the identity of the reviewers. A board member who is an author of a submission, or who works in the same department as its authors, takes no part in its review.
The journal publishes posters that have already been accepted for presentation by the scientific committee of a congress. This prior selection does not replace the review described above. The journal does not guarantee acceptance and does not promise a decision within a fixed time.
Editors and Editorial Board
The Editorial Board is listed on the Editorial Board page with the specialty and institution of each member. Members are practising physicians, surgeons, pharmacists and biologists.
Editors evaluate submissions on their scientific content only, without regard to the nationality, gender, institution or beliefs of the authors. They treat submissions as confidential and do not use unpublished material for their own work.
Conflicts of interest
Authors must disclose any financial or personal relationship that could influence the work, including funding and sponsorship. Reviewers and editors must decline to handle a submission when they have a conflict of interest.
Partners, sponsors and advertisers of the publisher take no part in the selection or the content of publications.
Research misconduct
The journal does not tolerate plagiarism, data fabrication or falsification, image manipulation, citation manipulation or duplicate publication presented as original work.
When an allegation of misconduct is received, before or after publication, the editors examine it following the guidelines of the Committee on Publication Ethics (COPE): the authors are asked to respond, and their institution may be informed. Depending on the outcome, the submission is rejected, or the publication is corrected or retracted.
Complaints and appeals
Authors may appeal an editorial decision by writing to the editorial office with their arguments; the appeal is examined by two board members who were not involved in the first decision.
Complaints about the conduct of the journal, its editors or its reviewers are sent to the same address and receive a written answer.
Corrections and retractions
An error that does not affect the conclusions is corrected, and the correction is recorded in the history of the publication. A publication whose results are unreliable, or that breaches this statement, is retracted: its page remains online with a retraction notice so that existing citations keep their meaning.
Readers may send comments on a published work to the editorial office; a substantiated comment is forwarded to the authors.
Data sharing and reproducibility
Authors are encouraged to make the data underlying their results available on request or in a public repository, and to state so on their poster. Patient data must never allow identification.
Ethical oversight
Research involving human participants must comply with the Declaration of Helsinki and with the regulations of the country where it was carried out, including approval by an ethics committee where required.
No publication may contain information that identifies a patient unless written consent has been obtained by the authors. The corresponding author confirms this by a signed agreement before publication.
Copyright and licensing
Authors retain copyright. Publications are released by default under the Creative Commons Attribution 4.0 license (CC BY 4.0); a CC BY-NC 4.0 license may be chosen at the authors’ request. Every publication is released under one of these two Creative Commons licenses. The license is shown on each publication and in its PDF.
Authors may deposit their poster and the published record in any repository without delay. Details are given on the Open access page.
Fees, access and revenue
Reading is free, without registration or embargo. Publishing is currently free of charge: there are no submission fees and no article processing charges. Any future fee would be announced in advance on the Open access page and would never apply to work already submitted.
The journal is owned, published and funded by MeetingsPremium LLC, a company registered in the State of Wyoming, United States. Fees or waivers have no influence on editorial decisions.
Advertising and direct marketing
The journal website carries no advertising within publications. Any sponsorship of the publisher is kept separate from editorial content and has no influence on editorial decisions.
Invitations to submit are sent only to authors who have presented a poster at a congress, name the journal and its publisher truthfully, and contain a one-click opt-out.
Use of automated tools
When a poster is submitted, an automated reading tool prepares a draft record (title, authors, abstract, key messages). The author checks and corrects every field before signing; nothing is published without this human validation. Automated tools are not used to make editorial decisions.
Archiving and preservation
Each publication has a permanent code and address. A DOI (DataCite) is assigned when the publication is deposited in Zenodo, the open archive operated by CERN, which preserves it independently of the journal website and registers it with DataCite, OpenAIRE and OpenAlex. Metadata can be harvested through the journal’s OAI-PMH interface.
Contact
Editorial office: contact@meetingspremium.com — MeetingsPremium LLC, 75 East 3rd Street, Sheridan, WY 82801, United States.
See also: Editorial Board · Instructions for authors · Open access